Aliment Pharmacol Ther
- SPINELLI I, Porcari S, Esposito C, Fusco W, et al
Meta-Analysis: Inverse Association Between Helicobacter pylori Infection and
Eosinophilic Oesophagitis.
Aliment Pharmacol Ther. 2025 Feb 24. doi: 10.1111/apt.70042.
Helicobacter
- ABDUN MA, Xu L, Li XT, Mekky A, et al
Global Prevalence of Helicobacter pylori Infection-Associated Gastric
Preneoplastic Lesions in Pediatric Patients: A Systematic Review and
Meta-Analysis.
Helicobacter. 2025;30:e70021.
- GIDDINGS HJ, Teodosio A, Jones J, McMurray JL, et al
The Gastric Microbiota Invade the Lamina Propria in Helicobacter
pylori-Associated Gastritis and Precancer.
Helicobacter. 2025;30:e70016.
- HU KY, Tseng PH, Liou JM, Tu CH, et al
Rebound of Reflux-Related Symptoms After Helicobacter pylori Eradication in
Patients With Gastroesophageal Reflux Disease: A Prospective Randomized Study.
Helicobacter. 2025;30:e70023.
- LIU YX, Liu HN, Liu HQ, Yang YY, et al
Vonoprazan-Amoxicillin Dual Therapy Versus Drug Sensitivity-Based Individualized
Therapy as a Rescue Regimen for Helicobacter pylori Infection: A Multicenter,
Randomized Controlled Trial.
Helicobacter. 2025;30:e70009.
Indian J Gastroenterol
- KHAN AZ, Khan S, Hameed H, Nasir S, et al
Critical insights: ABC score is a better predictor for 30-day mortality in upper
gastrointestinal bleeding-A prospective single-center study.
Indian J Gastroenterol. 2025 Feb 28. doi: 10.1007/s12664-025-01747.
- PEMMADA V, Shetty A, Bhat G
Reply to Khan et al., Critical Insights: ABC score is a better predictor for
30-day mortality in upper gastrointestinal bleeding: A prospective single-center
study.
Indian J Gastroenterol. 2025 Feb 22. doi: 10.1007/s12664-025-01750.
J Ethnopharmacol
- WANG M, Zhou J, Li L, Zhang T, et al
The anti-inflammatory effects of paeonol from Cynanchum paniculatum extracts on
LPS-induced macrophage RAW 264.7 cells and Helicobacter pylori-infected
gastrointestinal mucosal damaged zebrafish.
J Ethnopharmacol. 2025;344:119530.
Minerva Gastroenterol (Torino)
- BENETTI F, Gaio E, Agostini S
Barrier and protective effects of a newly developed medical device for the
treatment of gastroesophageal reflux disease.
Minerva Gastroenterol (Torino). 2025 Feb 27. doi: 10.23736/S2724-5985.25.03755.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016